{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:06:18Z","timestamp":1763755578166,"version":"3.45.0"},"reference-count":23,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1188\/14.cjon.360-362","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T21:51:53Z","timestamp":1401227513000},"page":"360-362","source":"Crossref","is-referenced-by-count":3,"title":["The Need for Routine Monitoring of Cardiac Function in Patients Receiving 5-Fluorouracil Infusion"],"prefix":"10.1188","volume":"18","author":[{"given":"Nataya","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0936-6555(98)80033-2","article-title":"Supraventricular Arrhythmia: A complication of 5-Fluorouracil","volume":"10","author":"S. Aziz","year":"1998","journal-title":"Clinical Oncology"},{"key":"2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2710.2004.00556.x","article-title":"Influence of high dose leucovorin and 5-fluorouracil chemotherapy regimen on p wave duration and dispersion","volume":"29","author":"C. Ceyhan","year":"2004","journal-title":"Journal of Clinical and Therapeutics"},{"key":"3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clcc.2012.09.003","article-title":"Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity","volume":"12","author":"G. Deboever","year":"2013","journal-title":"Clinical Colorectal Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.1992.10.11.1795","article-title":"Cardiotoxicity of high-dose continuous infusion fluorouracil: A prospective clinical trial","volume":"10","author":"M. De Forni","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1023\/A:1008263321681","article-title":"Noninvasive evaluation of cardiotoxicity of 5-flurouracil and low doses of folinic acid: A one year follow up study","volume":"8","author":"A. Grandi","year":"1997","journal-title":"Annals of Oncology"},{"key":"6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2459\/01.JCM.0000237914.12915.dd","article-title":"Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cisplatin","volume":"7","author":"E. Hrovatin","year":"2006","journal-title":"Journal of Cardiovascular Medicine"},{"key":"7","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1200\/JCO.2009.27.3953","article-title":"Fluorouracil induces myocardial ischemia with increase of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle","volume":"28","author":"S. Jensen","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00280-005-0178-1","article-title":"Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine","volume":"58","author":"S. Jensen","year":"2006","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00280-011-1669-x","article-title":"5-fluorouracil based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity","volume":"69","author":"S. Jensen","year":"2012","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","article-title":"Cardiotoxicity of fluoropyrimidines in different schedules of administration: A prospective study","volume":"134","author":"C. Kosmas","year":"2008","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"11","unstructured":"National Heart, Lung, and Blood Institute. (n.d.). How is angina treated? Retrieved from <a target=\"_blank\" href='http:\/\/www.nhlbi.nih.gov\/health\/\/dci\/Diseases\/Angina\/Angina_Treatments.html'>http:\/\/www.nhlbi.nih.gov\/health\/\/dci\/Diseases\/Angina\/Angina_Treatments.html<\/a>"},{"key":"12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jjco\/hyh047","article-title":"Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil\/folinic acid treatment by echocardiography, plasma troponin I level, qt interval and dispersion in patients with gastrointestinal system cancers","volume":"34","author":"I. Oztop","year":"2004","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"A. Polk","year":"2013","journal-title":"Cancer Treatment Reviews"},{"key":"14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19930115)71:2<493::AID-CNCR2820710235>3.0.CO;2-C","article-title":"The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy","volume":"71","author":"N. Robben","year":"1993","journal-title":"Cancer"},{"key":"15","first-page":"1051","article-title":"Cardiotoxicity of 5-FU","volume":"59","author":"A. Roth","year":"1975","journal-title":"Cancer Chemotherapy Reports"},{"key":"16","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/1097-0142(19931001)72:7<2242::AID-CNCR2820720730>3.0.CO;2-E","article-title":"Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer","volume":"72","author":"C. Sch\u00f6ber","year":"1993","journal-title":"Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5603\/CJ.2012.0084","article-title":"5-fluorouracil induced cardiotoxicity: Review of literature","volume":"19","author":"M. Sorrentino","year":"2012","journal-title":"Cardiology Journal"},{"key":"18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1748-717X-7-212","article-title":"5-FU-induced cardiac toxicity- an underestimated problem in radiooncology","volume":"7","author":"F. Steger","year":"2012","journal-title":"Radiation Oncology"},{"key":"19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/annonc\/mdh150","article-title":"5-fluorouracil induces arterial vasocontractions","volume":"15","author":"T. Sudhoff","year":"2004","journal-title":"Annals of Oncology"},{"key":"20","first-page":"151","article-title":"Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy- a survey of 427 patients","volume":"8","author":"N. Tsavaris","year":"2002","journal-title":"Medical Science Monitor"},{"key":"21","article-title":"Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease","volume":"93","author":"P. Tsibiribi","year":"2006","journal-title":"Bulletin Du Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9149(00)80079-X","article-title":"5-fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens","volume":"75","author":"B. Weidmann","year":"1995","journal-title":"American Journal of Cardiology"},{"key":"23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1742-1241.2007.01323.x","article-title":"5- fluorouracil increases the number and complexity of premature complexes in the heart: A prospective study using ambulatory ECG monitoring","volume":"61","author":"U. Yilmaz","year":"2007","journal-title":"International Journal of Clinical Practice"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/57815146UL817082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:53:58Z","timestamp":1763754838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/18\/3\/need-routine-monitoring-cardiac-function-patients-receiving-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6,1]]}},"alternative-id":["57815146UL817082"],"URL":"https:\/\/doi.org\/10.1188\/14.cjon.360-362","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2014,5,27]]}}}